Actively Recruiting
Strategic Targeting for Optimal Prevention of Cancer
Led by ClinLogic LLC · Updated on 2026-03-19
120000
Participants Needed
1
Research Sites
196 weeks
Total Duration
On this page
Sponsors
C
ClinLogic LLC
Lead Sponsor
M
MDGlobal
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.
CONDITIONS
Official Title
Strategic Targeting for Optimal Prevention of Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals aged 65 years or older
- Must have met medical necessity for hereditary cancer genomic testing and allowed physician to test based on medical necessity
- Hereditary cancer diagnostic test was ordered by a physician related to individual subject care
- Study subject has or had cancer
- Study subject has at least one family member with current or past cancer
You will not qualify if you...
- Currently hospitalized or incarcerated
- Unable to provide an accurate history due to mental incapacity
- Currently abusing illicit and/or prescription drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sunbeam Clinical
Prosper, Texas, United States, 75078
Actively Recruiting
Research Team
C
C David, MBA
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here